Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Brant

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Inflammatory Bowel Diseases|January 30, 2009
Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel diseaseGeoffrey C Nguyen, Thomas A LaVeist, Mary L Harris, et al.
The American Journal of Gastroenterology|May 21, 2010
Racial disparities in utilization of specialist care and medications in inflammatory bowel diseaseGeoffrey C Nguyen, Thomas A LaVeist, Mary L Harris, et al.
Science Translational Medicine|June 8, 2018
An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitisTetsuya Takagawa, Atsushi Kitani, Ivan Fuss, et al.
Gastroenterology|May 9, 2017
ReplyDavid T Okou, Steven R Brant, Claire L Simpson, et al.
HGG Advances|September 18, 2025
Aberrant N-glycosylation may be a therapeutic target in carriers of a common and highly pleiotropic variant in the manganese transporter ZIP8Vartika Tomar, John Kang, Ruxian Lin, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Aberrant N-glycosylation is a therapeutic target in carriers of a common and highly pleiotropic mutation in the manganese transporter ZIP8Vartika Tomar, John Kang, Ruxian Lin, et al.
Inflammatory Bowel Diseases|September 3, 2010
Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's diseaseFeng Wu, Natalie Jia Guo, Hongying Tian, et al.
Inflammatory Bowel Diseases|June 4, 2008
Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactionsToshihiko Okazaki, Ming-Hsi Wang, Patricia Rawsthorne, et al.
Journal of Digestive Diseases|January 20, 2012
6-Mercaptopurine transport in human lymphocytes: correlation with drug-induced cytotoxicityLaurie S Conklin, Carmen Cuffari, Toshihiko Okazaki, et al.
Inflammatory Bowel Diseases|September 18, 2010
Identification of microRNAs associated with ileal and colonic Crohn's diseaseFeng Wu, Simin Zhang, Themistocles Dassopoulos, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Inflammatory Bowel Diseases|January 30, 2009
Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel diseaseGeoffrey C Nguyen, Thomas A LaVeist, Mary L Harris, et al.
The American Journal of Gastroenterology|May 21, 2010
Racial disparities in utilization of specialist care and medications in inflammatory bowel diseaseGeoffrey C Nguyen, Thomas A LaVeist, Mary L Harris, et al.
Science Translational Medicine|June 8, 2018
An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitisTetsuya Takagawa, Atsushi Kitani, Ivan Fuss, et al.
Gastroenterology|May 9, 2017
ReplyDavid T Okou, Steven R Brant, Claire L Simpson, et al.
HGG Advances|September 18, 2025
Aberrant N-glycosylation may be a therapeutic target in carriers of a common and highly pleiotropic variant in the manganese transporter ZIP8Vartika Tomar, John Kang, Ruxian Lin, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Aberrant N-glycosylation is a therapeutic target in carriers of a common and highly pleiotropic mutation in the manganese transporter ZIP8Vartika Tomar, John Kang, Ruxian Lin, et al.
Inflammatory Bowel Diseases|September 3, 2010
Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's diseaseFeng Wu, Natalie Jia Guo, Hongying Tian, et al.
Inflammatory Bowel Diseases|June 4, 2008
Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactionsToshihiko Okazaki, Ming-Hsi Wang, Patricia Rawsthorne, et al.
Journal of Digestive Diseases|January 20, 2012
6-Mercaptopurine transport in human lymphocytes: correlation with drug-induced cytotoxicityLaurie S Conklin, Carmen Cuffari, Toshihiko Okazaki, et al.
Inflammatory Bowel Diseases|September 18, 2010
Identification of microRNAs associated with ileal and colonic Crohn's diseaseFeng Wu, Simin Zhang, Themistocles Dassopoulos, et al.
Pageof 13